PHYSIOLOGICAL BASIS OF THE CARE OF THE ELDERLY CLIENT The Musculoskeletal System 1

Embed Size (px)

Citation preview

  • Slide 1
  • PHYSIOLOGICAL BASIS OF THE CARE OF THE ELDERLY CLIENT The Musculoskeletal System 1
  • Slide 2
  • Patient scenario 2 J.H. is a 76 year old female brought in by her granddaughter with whom she lives. The granddaughter states J.H. complains of her joints hurting and she is mean and wont listen to her. J.H. states all her joints hurt and shed rather just stay in bed all day. She is afraid J.H. will hurt herself as she has fallen twice while the granddaughter is at work.
  • Slide 3
  • Informal evaluation 3 What additional information do you need? Subjective information Objective information Psychosocial information
  • Slide 4
  • Structure and function of joints 4 Point at which 2 bones are attached Provide stability and mobility to the skeleton A joint that is unstable or immobile is ineffective! Nursing diagnoses originate from cause of the ineffective joint: Impaired physical mobility Acute pain or chronic pain Fatigue
  • Slide 5
  • Age related changes 5 Decreased range of motion Shrinking vertebral discs and loss of bone mass contribute to decrease in height Muscle atrophy, exacerbated by disuse Decrease in lean body mass Joint degeneration Postural instability contributes to balance difficulties Difficulty maintaining balance
  • Slide 6
  • Incredible shrinking people 6 After age 40, loss of 1 cm in height every decade is normal Vertebral deterioration due to osteoporosis 23 spinal compress during the day and reabsorb fluid during night, causing a half- inch variation With age, the discs flatten reducing height permanently
  • Slide 7
  • Sarcopenia 7 Loss of muscle mass, strength, function Maximum muscle strength can decrease by 85% Occurs in up to 50% patients 80 years +
  • Slide 8
  • Treatment for sarcopenia 8 The primary treatment for sarcopenia is exercise. Resistance training with resistance bands Strength training with weights Effective for both prevention and treatment of sarcopenia Positive influence on Neuromuscular system Hormone concentrations Can increase protein synthesis rates in older adults in as little as two weeks.
  • Slide 9
  • Classification of musculoskeletal illnesses 9 Metabolic bone disease OsteoporosisOsteomalacia Pagets disease Joint disease Osteoarthritis (noninflammatory) Rheumatoid arthritis (inflammatory) Gout (inflammatory) Pseudogout (inflammatory)
  • Slide 10
  • Osteoporosis (Metabolic bone disease ) 10 Low bone mass Deterioration of bone tissue Affects 50% of women Contributors to decreased bone mass in the elderly 1) failure to achieve peak bone mass in early adulthood 2) increased bone resorption 3) decreased bone formation
  • Slide 11
  • Risk factors for osteoporosis 11 Risk factors include: Increased age Female White or Asian Family history Thin body build Also implicated: low calcium intake, smoking, alcohol, caffeine, stress, long term corticosteroids, anticonvulsants, thyroid medications
  • Slide 12
  • Diagnostics for osteoporosis 12 Bone mineral density study recommended for: Postmenopausal women below age 65 with risk factors for osteoporosis. All women aged 65 and older. Postmenopausal women with fractures Women with medical conditions associated with osteoporosis. Women whose decision to use medication might be aided by bone density testing. Men age 70 or older. Men ages 50-69 with risk factors for osteoporosis.
  • Slide 13
  • Diagnostic tests: bone mineral density study 13 Used to predict fracture Recommended for most women > 65 years of age Recommended for those < 65 if: Chronic rheumatoid arthritis Fracture Early menopause Smoking Family history of osteoporosis Taking corticosteroids Consume > 3 drinks of alcohol per day
  • Slide 14
  • Lifestyle modifications for the patient with osteoporosis Diet with adequate calcium and vitamin D Weight bearing exercise (increase bone density) Smoking cessation Reduction of alcohol, caffeine 14
  • Slide 15
  • Medications for osteoporosis 15 Biphosphates Alendronate (Fosamax)daily or weekly Ibandronate (Boniva)daily or monthly or q 3 months IV Estrogen agonists/antagonists Raloxifene (Evista)daily Calcitonin (Miacalcin)daily
  • Slide 16
  • Examples of weight bearing exercise Dumbells Resistance band Bodyweight exercise Calisthenics Weight machine exercise 16
  • Slide 17
  • Pharmacological prevention & treatment of osteoporosis 17 Ibandronate (Boniva) Once a month or IV every 3 months Alendronate (Fosamax) Once weekly Empty stomach Upright for at least 30 minutes Raloxifene hydrochloride (Evista) Once daily May take without regard for food May cause flushing Increased risk of thromboembolic events Weight bearing exercise important in all cases!
  • Slide 18
  • Osteomalacia ( Metabolic bone disease) 18 Softening of the bones: volume of bone is adequate, replacement is soft and not rigid Defective bone mineralization Inadequate available phosphorus and calcium Can be caused by increased resorption of calcium due to hyperparathyroidism
  • Slide 19
  • Diagnostics for osteomalacia 19 Bone density studies Alkaline phosphatase is elevated Serum calcium is low
  • Slide 20
  • Treatment of osteomalacia 20 Goal is to remineralize the bone Vitamin D replacement 50,000-100,000 units/day for 1-2 weeks 400 to 800 units daily Must have adequate calcium intake 1000 to 1500 mg/day Monitor serum and urine calcium levels
  • Slide 21
  • Pagets disease (Metabolic bone disease) 21 Chronic, localized disorder Normal bone removed, replaced with abnormal bone Cause is unknown Often an incidental finding Common symptom is bone pain at site or adjacent joints
  • Slide 22
  • Diagnostics for Pagets disease 22 Xrays, bone scan, CT Serum calcium low or normal May require bone biopsy:
  • Slide 23
  • Treatment of Pagets disease 23 Deformities are irreversible Treatment goals Relieve bone pain Prevent progression Medications of choice Alendronate (Fosamax) Risendronate (Actonel)
  • Slide 24
  • Osteoarthritis (Joint diseasenoninflammatory) 24 Most common form of arthritis in the US Chronic Women > men Progressive erosion of articular cartilage of the joint New bone forms in the joint space
  • Slide 25
  • Clinical manifestations osteoarthritis 25 Characteristic nodule formation:
  • Slide 26
  • Diagnostics for osteoarthritis 26 Xrayjoint space narrowing, spur formation
  • Slide 27
  • Treatment goals 27
  • Slide 28
  • Rheumatoid arthritis (Joint diseaseinflammatory) 28 Most common inflammatory arthritis of any age group Women:men 3:1 Chronic syndrome Symmetrical inflammation of peripheral joints Likely an autoimmune response to unidentified antigen
  • Slide 29
  • Clinical manifestations of rheumatoid arthritis 29 Commonly occurs in: Joints of upper extremities Knees Ankles Feet Systemic symptoms: Fatigue, malaise Weight loss Fever
  • Slide 30
  • Diagnostics for rheumatoid arthritis 30 Xraysymmetrical disease Synovial fluid aspiration WBC and ESR in 80% of cases Rheumatoid factor (RF) in 50% of cases
  • Slide 31
  • Osteoarthritis vs rheumatoid arthritis 31
  • Slide 32
  • Osteoarthritis vs rheumatoid arthritis 32 OsteoarthritisRheumatoid Arthritis Red, swollen, tender Affects internal organs Most common form Wear and tear Bilateral symmetry Morning stiffness >30 min Pain improves during day Nodules (Bouchards) Primarily in cartilage Primarily in synovium
  • Slide 33
  • Pharmacological interventions for osteoarthritis 33 NSAIDs are most common treatment Acetaminophen 500 mg2-4 grams per day Capsaicintopical analgesic
  • Slide 34
  • Nonpharmacological treatment of osteoarthritis 34 Weight reduction Active range of motion daily Weight bearing exercise Rest to control symptoms Use of assistive devices if necessary
  • Slide 35
  • Importance of exercise 35 Maintain overall function Maintain muscle strength Maintain coordination Maintain balance Maintain flexibility Maintain endurance
  • Slide 36
  • Exercise programs 36 Require clearance by PCP Start slow, low impact, gradually increase
  • Slide 37
  • Pharmacological interventions for rheumatoid arthritis 37 Corticosteroids (e.g., prednisone) to decrease inflammation May have long-term adverse effects NSAIDs Quick relief important to preserve independence
  • Slide 38
  • Nonpharmacological treatment of rheumatoid arthritis 38 Strength training to address muscle wasting Range of motion of joints Regular exercise if no inflammation or exacerbation Rest to reduce joint stress
  • Slide 39
  • In profile, should be a slight reverse S Posteriorly, midline without deviation, shoulders even 39 Spine
  • Slide 40
  • Standing Uneven shoulder height Unequal distance between arms and body Asymmetrical waistline Uneven hip height Sideways lean Bending over Asymmetrical thoracic spine Prominent rib cage/hump on either side Asymmetrical waistline 40 Testing for scoliosis
  • Slide 41
  • Gout (joint diseaseinflammatory) 41 Excessive uric acid in blood Crystals accumulate in joints Warmth, redness, swelling, pain Low purine diet Diagnosisurate crystals in affected joint
  • Slide 42
  • Treatment of gout 42 Acute attacks: NSAIDs Colchicine Steroids Long term manage- ment: Colchicine Allopurinol (Zyloprim) Probenicid Indomethacin (Indocin)
  • Slide 43
  • Pseudogout (joint diseaseinflammatory) 43 Actually a form of arthritis Formation of calcium pyrophosphate-dihydrate crystals in large joints 60 years+ Women > men Develops in families Affects several joints Diagnosed by joint fluid aspiration
  • Slide 44
  • Falls 44 Most occur in the home during normal activities Leading cause of accidental death Commonly result in fractures of hip, spine, forearm Of all fall-related fractures, hip fracture is most likely
  • Slide 45
  • Contributing factors to falls 45 Visual changes Balance problems Cognitive changes CV problems Medications Urinary incontinence, urgency Malnutrition Musculoskeletal impairment
  • Slide 46
  • Balance exercises for the elderly 46 Reinforce balance exercises:
  • Slide 47
  • Treatment of hip fractures 47 Surgery is preferred treatment Should be performed without delay if tolerable May not be an option for severely debilitated patient Total joint replacement performed if severe arthritis is present
  • Slide 48
  • Fall assessment: Get up and go test 48 Technique: Direct patient to do the following Rise from sitting position Walk 10 feet Turn around Return to chair and sit down Interpretation Patient takes 30 seconds to complete test Suggests higher dependence and risk of falls
  • Slide 49
  • Diagnostic tests: computerized tomography vs magnetic resonance 49 Computerized tomography (CT) Can detect inflammation and degeneration not visible on xray Can show subtle fractures and articular damage Magnetic resonance imaging (MRI) More detailed image Does not require radiation or contrast Can detect soft tissue changes
  • Slide 50
  • Gait changes in the elderly 50 Gait velocity unchanged until about 70 years Cadence (steps per minute) does not change Time with both feet on the ground increases from 18% in young adults to about 26% healthy elderly Anterior pelvic rotation increases partly due to weak pelvic muscles Joint motion changes slightly
  • Slide 51
  • Abnormal changes in gait in the elderly 51 Loss of symmetry of movement Difficulty initiating or maintaining gait Walking, falling backwards (retropulsion) Footdrop Short step length Wide based gait Progressive quickening to avoid falling forward (festination) as with Parkinsons
  • Slide 52
  • Formal evaluation What is your nursing diagnosis for J.H.? What is your desired outcome? What are appropriate interventions pertinent to your desired outcome? 52